R/S almost never work or benefit the shareholders.
Post# of 157744
(Total Views: 490)
Posted On: 11/18/2022 4:59:52 AM
Re: chazzledazzle #130465
R/S almost never work or benefit the shareholders.
Secondly have we even sold any of the new shares recently. Let’s talk about that, don’t they need money again soon? What’s the hold up.
Secondly have we even sold any of the new shares recently. Let’s talk about that, don’t they need money again soon? What’s the hold up.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://zenodo.org/records/17290045?token=eyJ...UkeT_EvKIQ
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://zenodo.org/records/17290045?token=eyJ...UkeT_EvKIQ
— Jeremiah 51:36